RU2006101987A - Трициклические производные или их фармацевтически приемлемые соли, способы их получения и содержащие их фармацевтические композиции - Google Patents
Трициклические производные или их фармацевтически приемлемые соли, способы их получения и содержащие их фармацевтические композиции Download PDFInfo
- Publication number
- RU2006101987A RU2006101987A RU2006101987/04A RU2006101987A RU2006101987A RU 2006101987 A RU2006101987 A RU 2006101987A RU 2006101987/04 A RU2006101987/04 A RU 2006101987/04A RU 2006101987 A RU2006101987 A RU 2006101987A RU 2006101987 A RU2006101987 A RU 2006101987A
- Authority
- RU
- Russia
- Prior art keywords
- heptalen
- tetrahydrobenzo
- methylsulfanyl
- oxo
- trimethoxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C321/00—Thiols, sulfides, hydropolysulfides or polysulfides
- C07C321/22—Thiols, sulfides, hydropolysulfides, or polysulfides having thio groups bound to carbon atoms of rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
- C07C323/40—Y being a hydrogen or a carbon atom
- C07C323/41—Y being a hydrogen or an acyclic carbon atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C381/00—Compounds containing carbon and sulfur and having functional groups not covered by groups C07C301/00 - C07C337/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
- C07C2603/30—Ortho- or ortho- and peri-condensed systems containing three rings containing seven-membered rings
- C07C2603/34—Benzoheptalenes; Hydrogenated benzoheptalenes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Furan Compounds (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Claims (5)
1. Трициклическое производное, представленное следующей формулой 1, или его фармацевтически приемлемые соли.
где (1) R1 представляет -Т1-B1;
где T1 представляет -N(R5)C(O)-, где R5 представляет H или C1-C5 алкильную группу; и
B1 выбирают из группы, состоящей из следующих значений (a)-(с):
где
R6 представляет H или галоген;
R7 представляет гидрокси или -ONO2 группу, при условии, что если R6 представляет Н, R7 представляет -ONO2 группу;
T2 представляет -O-С(О)-;
B2 представляет указанную группу (a) или -(СН2)n3-R7;
n1 представляет целое число 0-1;
n2 представляет целое число 0-5; и
n3 представляет целое число 2-5;
(2) R2 представляет CH3;
(3) R3 представляет C1-C4 неразветвленный или разветвленный алкил, или C3-C7 циклоалкил, при условии, что если В1 представляет (а) и R6 представляет Н, тогда R3 представляет С2Н5.
2. Трициклическое производное или его фармацевтически приемлемые соли по п.1, где трициклическое производное выбирают из группы, состоящей из
1) 6-нитрооксиметил-N-[(7S)-1,2,3-триметокси-l0-метилсульфанил-9-оксо-5,6,7,9-тетрагидробензо[a]гептален-7-ил]никотинамида;
4) N-[(7S)-3-этокси-l,2-диметокси-10-метилсульфанил-9-оксо-5,6,7,9-тетрагидробензо[a]гептален-7-ил]-3-нитрооксиметилбензамида;
5) [(7S)-l,2,3-триметокси-10-метилсульфанил-9-оксо-5,6,7,9-тетрагидробензо[a]гептален-7-ил]амида 6-нитрооксиметилпиридин-2-карбоновой кислоты;
6) [(7S)-1,2,3-триметокси-10-метилсульфанил-9-оксо-5,6,7,9-тетрагидробензо[a]гептален-7-ил]амида 5-нитрооксиметилтиофен-2-карбоновой кислоты;
8) N-[(7S)-3-этокси-l,2-диметокси-10-метилсульфанил-9-оксо-5,6,7,9-тетрагидробензо[a]гептален-7-ил]-2-фтор-3-нитрооксиметилбензамида;
9) 2-фтор-N-[(7S)-3-изопропокси-l,2-диметокси-10-метилсульфанил-9-оксо-5,6,7,9-тетрагидробензо[a]гептален-7-ил]-3-нитрооксиметилбензамида;
10) 2-фтор-3-нитрооксиметил-N-[(7S)-1,2,3-триметокси-10-метилсульфанил-9-оксо-5,6,7,9-тетрагидробензо[a]гептален-7-ил]бензамида;
12) 3-фтор-5-нитрооксиметил-N-[(7S)-1,2,3-триметокси-10-метилсульфанил-9-оксо-5,6,7,9-тетрагидробензо[a]гептален-7-ил]бензамида;
13) N-[(7S)-3-этокси-l,2-диметокси-10-метилсульфанил-9-оксо-5,6,7,9-тетрагидробензо[a]гептален-7-ил]-3-фтор-5-нитрооксиметилбензамида;
14) 3-фтор-N-[(7S)-3-изопропокси-1,2-диметокси-10-метилсульфанил-9-оксо-5,6,7,9-тетрагидробензо[a]гептален-7-ил]- 5-нитрооксиметилбензамида;
15) N-[(7S)-3-циклопентилокси-l,2-диметокси-10-метилсульфанил-9-оксо-5,6,7,9-тетрагидробензо[a]гептален-7-ил]-3-фтор-5-нитрооксиметилбензамида;
17) 2-фтор-5-нитрооксиметил-N-[(7S)-1,2,3-триметокси-10-метилсульфанил-9-оксо-5,6,7,9-тетрагидробензо[a]гептален-7-ил]бензамида;
21) [(7S)-l,2,3-триметокси-10-метилсульфанил-9-оксо-5,6,7,9-тетрагидробензо[a]гептален-7-ил]амида 4-нитрооксиметилтиофен-2-карбоновой кислоты;
22) [(7S)-l,2,3-триметокси-10-метилсульфанил-9-оксо-5,6,7,9-тетрагидробензо[a]гептален-7-ил]амида 3-нитрооксиметилтиофен-2-карбоновой кислоты;
29) 2-[(7S)-1,2,3-триметокси-10-метилсульфанил-9-оксо-5,6,7,9-тетрагидробензо[a]гептален-7-илкарбамоил]фенилового эфира 3-нитрооксиметилбензойной кислоты;
30) 2-[(7S)-1,2,3-триметокси-10-метилсульфанил-9-оксо-5,6,7,9-тетрагидробензо[a]гептален-7-илкарбамоил]фенилового эфира 4-нитрооксимасляной кислоты;
31) 3-[(7S)-1,2,3-триметокси-l0-метилсульфанил-9-оксо-5,6,7,9-тетрагидробензо[a]гептален-7-илкарбамоил]фенилового эфира 3-нитрооксиметилбензойной кислоты;
32) 3-[(7S)-1,2,3-триметокси-10-метилсульфанил-9-оксо-5,6,7,9-тетрагидробензо[a]гептален-7-илкарбамоил]фенилового эфира 4-нитрооксимасляной кислоты;
33) 3-[(7S)-1,2,3-триметокси-10-метилсульфанил-9-оксо-5,6,7,9-тетрагидробензо[a]гептален-7-илкарбамоил]бензилового эфира 3-нитрооксиметилбензойной кислоты;
34) 3-[(7S)-1,2,3-триметокси-10-метилсульфанил-9-оксо-5,6,7,9-тетрагидробензо[a]гептален-7-илкарбамоил]бензилового эфира 4-нитрооксимасляной кислоты;
3. Способ получения трициклических производных по способу, представленному на схеме 1, включающий следующие стадии:
(1) взаимодействие соединения формулы (III) с соединением формулы (IV) или соединением формулы (VI) с получением соединения формулы (V) или соединения формулы (VII), или взаимодействие полученного соединения формулы (VII) с галогенсодержащим соединением с получением соединения формулы (V) (стадия 1); и
(2) нитрование или нитрозирование полученного соединения формулы (V) или соединения формулы (VII) с получением соединения формулы (IIa) (стадия 2)
Схема 1
и R2, R3, R4 и X имеют указанные для формулы 1 значения;
R5 представляет H или C1-C5 алкильную группу;
X1 представляет O;
Hal1 и Hal2 представляют галогены;
Hal1 и Hal2 в формуле (IV), каждый, одинаковы или различны и представляют галогены, например F, Cl, Br или I; Y выбирают из группы, состоящей из соединений формул (a') и (b')
4. Противораковый агент или противопролиферативный агент, содержащий в качестве эффективного ингредиента трициклическое производное по п.1 или 2, или их фармацевтически приемлемые соли.
5. Ингибитор ангиогенеза, содержащий в качестве эффективного ингредиента трициклическое производное по п.1 или 2, или их фармацевтически приемлемые соли.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2003-0041547 | 2003-06-25 | ||
KR20030041547 | 2003-06-25 |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2006101987A true RU2006101987A (ru) | 2006-07-10 |
RU2326864C2 RU2326864C2 (ru) | 2008-06-20 |
Family
ID=36091400
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2006101987/04A RU2326864C2 (ru) | 2003-06-25 | 2004-06-23 | Трициклические производные или их фармацевтически приемлемые соли, способы их получения и содержащие их фармацевтические композиции |
Country Status (14)
Country | Link |
---|---|
US (1) | US20070179143A1 (ru) |
EP (1) | EP1646608B1 (ru) |
JP (1) | JP4430071B2 (ru) |
KR (1) | KR100667464B1 (ru) |
CN (1) | CN100393698C (ru) |
AT (1) | ATE500216T1 (ru) |
AU (1) | AU2004249639B2 (ru) |
CA (1) | CA2531543C (ru) |
DE (1) | DE602004031621D1 (ru) |
DK (1) | DK1646608T3 (ru) |
ES (1) | ES2358801T3 (ru) |
HK (1) | HK1095133A1 (ru) |
RU (1) | RU2326864C2 (ru) |
WO (1) | WO2004113281A1 (ru) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7622612B2 (en) | 2001-05-28 | 2009-11-24 | Chemtech Research Incorporation | Tricyclic derivatives and their use |
US7507842B2 (en) | 2005-08-12 | 2009-03-24 | Radiorx, Inc. | Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof |
US20070135380A1 (en) * | 2005-08-12 | 2007-06-14 | Radiorx, Inc. | O-nitro compounds, pharmaceutical compositions thereof and uses thereof |
PT1988085E (pt) | 2006-02-21 | 2015-02-05 | Toyama Chemical Co Ltd | Processo para a produção de éster de propionato de 3-[5-[4-(ciclopentiloxi)-2-hidroxibenzoil]-2-[(3- hidroxi-1,2-benzisoxazol-6-il)metoxi]fenilo] e produtos intermédios para o processo |
KR101077609B1 (ko) * | 2009-07-08 | 2011-10-27 | 제일약품주식회사 | 트리사이클릭 유도체의 제조방법 |
ES2745255T3 (es) | 2009-08-26 | 2020-02-28 | Alberta Health Services | Derivados de colchicina novedosos, métodos y usos de los mismos |
US8471041B2 (en) | 2010-02-09 | 2013-06-25 | Alliant Techsystems Inc. | Methods of synthesizing and isolating N-(bromoacetyl)-3,3-dinitroazetidine and a composition including the same |
KR101130754B1 (ko) * | 2010-06-25 | 2012-03-28 | 제일약품주식회사 | 난용성 트리사이클릭 유도체 화합물의 용해도가 향상된 약학적 조성물 |
US8664247B2 (en) | 2011-08-26 | 2014-03-04 | Radiorx, Inc. | Acyclic organonitro compounds for use in treating cancer |
WO2013052803A2 (en) | 2011-10-07 | 2013-04-11 | Radiorx, Inc. | Methods and compositions comprising a nitrite-reductase promoter for treatment of medical disorders and preservation of blood products |
WO2013052164A1 (en) | 2011-10-07 | 2013-04-11 | Radiorx, Inc. | Organonitro thioether compounds and medical uses thereof |
KR101494280B1 (ko) * | 2012-12-28 | 2015-02-23 | 한국화학연구원 | 콜치신 유도체를 유효성분으로 포함하는 암의 예방 또는 치료용 조성물 |
CN104649943B (zh) * | 2015-01-28 | 2016-10-05 | 中国科学院上海高等研究院 | 秋水仙碱衍生物及其制备方法和应用 |
US10342778B1 (en) | 2015-10-20 | 2019-07-09 | Epicentrx, Inc. | Treatment of brain metastases using organonitro compound combination therapy |
US9987270B1 (en) | 2015-10-29 | 2018-06-05 | Epicentrix, Inc. | Treatment of gliomas using organonitro compound combination therapy |
US11576895B2 (en) | 2016-01-11 | 2023-02-14 | Epicentrx, Inc | Compositions and methods for intravenous administration of 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethanone |
WO2017148902A1 (de) | 2016-03-03 | 2017-09-08 | Bayer Pharma Aktiengesellschaft | Neue 2-substituierte indazole, verfahren zu ihrer herstellung, pharmazeutische präparate die diese enthalten, sowie deren verwendung zur herstellung von arzneimitteln |
WO2017207385A1 (de) | 2016-05-31 | 2017-12-07 | Bayer Pharma Aktiengesellschaft | Substituierte 3-methylindazole, verfahren zu ihrer herstellung, pharmazeutische präparate, die diese enthalten, sowie deren verwendung zur herstellung von arzneimitteln |
SG11201809470RA (en) | 2016-06-01 | 2018-11-29 | Bayer Animal Health Gmbh | Substituted indazoles useful for treatment and prevention of allergic and/or inflammatory diseases in animals |
WO2018060174A1 (de) | 2016-09-29 | 2018-04-05 | Bayer Pharma Aktiengesellschaft | Substituierte benzimidazole, pharmazeutische präparate diese enthaltend, sowie deren verwendung zur herstellung von arzneimitteln |
JP7332469B2 (ja) | 2016-10-14 | 2023-08-23 | エピセントアールエックス,インコーポレイテッド | スルホキシアルキル有機窒素および関連のある化合物ならびに医学における使用のための医薬組成物 |
CN109843862B (zh) * | 2016-10-26 | 2021-10-29 | 石原产业株式会社 | 3-甲基-2-噻吩羧酸的制造方法 |
MX2020000265A (es) | 2017-07-07 | 2020-07-22 | Epicentrx Inc | Composiciones para la administración parenteral de agentes terapéuticos. |
US11510901B2 (en) | 2018-01-08 | 2022-11-29 | Epicentrx, Inc. | Methods and compositions utilizing RRx-001 combination therapy for radioprotection |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4533675A (en) | 1984-04-17 | 1985-08-06 | The United States Of America As Represented By The Department Of Health And Human Services | Carbamates of colchicine for treatment of gout |
IT1276996B1 (it) * | 1995-06-27 | 1997-11-04 | Indena Spa | Derivati della colchicina, loro uso e formulazioni che li contengono |
IT1291550B1 (it) | 1997-04-11 | 1999-01-11 | Indena Spa | Derivati della colchicina e della tiocolchicina ad attivita' antinfiammatoria e miorilassante |
US7119229B2 (en) * | 2001-05-28 | 2006-10-10 | Chemtech Research Incorporation | Alkaloid derivative and a pharmaceutical composition containing the same |
-
2004
- 2004-06-23 JP JP2006515341A patent/JP4430071B2/ja active Active
- 2004-06-23 DE DE602004031621T patent/DE602004031621D1/de active Active
- 2004-06-23 CN CNB2004800212673A patent/CN100393698C/zh active Active
- 2004-06-23 ES ES04773996T patent/ES2358801T3/es active Active
- 2004-06-23 EP EP04773996A patent/EP1646608B1/en active Active
- 2004-06-23 AU AU2004249639A patent/AU2004249639B2/en not_active Ceased
- 2004-06-23 KR KR1020040047277A patent/KR100667464B1/ko active IP Right Grant
- 2004-06-23 CA CA2531543A patent/CA2531543C/en not_active Expired - Fee Related
- 2004-06-23 US US10/562,615 patent/US20070179143A1/en not_active Abandoned
- 2004-06-23 RU RU2006101987/04A patent/RU2326864C2/ru not_active IP Right Cessation
- 2004-06-23 AT AT04773996T patent/ATE500216T1/de active
- 2004-06-23 WO PCT/KR2004/001518 patent/WO2004113281A1/en active Application Filing
- 2004-06-23 DK DK04773996.6T patent/DK1646608T3/da active
-
2007
- 2007-02-27 HK HK07102213.0A patent/HK1095133A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU2004249639B2 (en) | 2008-07-17 |
ES2358801T3 (es) | 2011-05-13 |
JP2007520422A (ja) | 2007-07-26 |
DE602004031621D1 (de) | 2011-04-14 |
CA2531543C (en) | 2010-10-12 |
DK1646608T3 (da) | 2011-06-14 |
AU2004249639A1 (en) | 2004-12-29 |
JP4430071B2 (ja) | 2010-03-10 |
HK1095133A1 (en) | 2007-04-27 |
EP1646608B1 (en) | 2011-03-02 |
CN1826316A (zh) | 2006-08-30 |
KR100667464B1 (ko) | 2007-01-10 |
WO2004113281A1 (en) | 2004-12-29 |
CN100393698C (zh) | 2008-06-11 |
US20070179143A1 (en) | 2007-08-02 |
KR20050001383A (ko) | 2005-01-06 |
RU2326864C2 (ru) | 2008-06-20 |
EP1646608A1 (en) | 2006-04-19 |
ATE500216T1 (de) | 2011-03-15 |
EP1646608A4 (en) | 2006-11-22 |
CA2531543A1 (en) | 2004-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2006101987A (ru) | Трициклические производные или их фармацевтически приемлемые соли, способы их получения и содержащие их фармацевтические композиции | |
RU2000125568A (ru) | Производные циклоалкенов, их получение и применение | |
CS240998B2 (en) | Production method of 1,4-dihydropiridines | |
FI914961A0 (fi) | Peptidfoereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutisk blandning. | |
RU2003122190A (ru) | Производные тетрагидропиридина, их получение и применение в качестве ингибиторов клеточной пролиферации | |
RU2004137480A (ru) | Ингибиторы вируса гепатита с | |
RU2007110629A (ru) | Ингибиторы днк-пк | |
RU2008119465A (ru) | Производные циклопропилуксусной кислоты и их применение | |
CA2529347A1 (en) | Use of oxazolidinone-quinoline hybrid antibiotics for the treatment of anthrax and other infections | |
RU98108553A (ru) | Фармацевтические композиции, содержащие производные гидроксимикоевой кислоты | |
SU1364237A3 (ru) | Способ получени производных 1,4-дигидропиридина или их гидрохлоридов | |
EP2321323B1 (fr) | Derives dimeriques d'artemisinine et application en therapie anticancereuse | |
JP2003221386A5 (ru) | ||
RU2003134629A (ru) | Соединения цефема | |
EA200500095A1 (ru) | Производные 4-(7-гало-2-хино(кса-)линилокси)феноксипропионовой кислоты в качестве противоопухолевых средств | |
JP2005511535A5 (ru) | ||
DE68926981D1 (de) | Cephemverbindungen und Verfahren zu ihrer Herstellung | |
RU97118134A (ru) | Новые противовирусные гомокарбоциклические нуклеозидные производные замещенных пиримидиндионов, способы их получения и композиции, содержащие их в качестве активных ингредиентов | |
RU96101173A (ru) | Производные пиридазинонов | |
KR970703301A (ko) | 신규 디아미노메틸리덴 유도체(novel diamincmethylidene derivative) | |
RU2009123645A (ru) | Способы повышения биодоступности ингибитора ренина | |
KR950701329A (ko) | 벤조티아졸술폰아미드 유도체, 그의 제조법 및 그 용도(Benzothiazolesulfornamide derivative, method for preparing the same, and use thereof) | |
RU99109978A (ru) | Бис(акридинкарбоксамид) и бис(феназинкарбоксамид), полезные в качестве противоопухолевых агентов | |
RU94031745A (ru) | Производные пиридобензоксадиазина, смесь их изомеров или отдельные изомеры, их гидраты и соли, способ их получения и фармацевтическая композиция с антибактериальной активностью | |
RU2007108657A (ru) | Органические соединения |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20170624 |